Recipient Outcomes Following Transplantation of Allografts From Live Kidney Donors Who Subsequently Developed End-Stage Renal Disease

American Journal of Transplantation

Volumn 16, Issue 12, 2016, Pages 3532-3539

  Muzaale, A D ^a   Massie, A B ^a,b   Anjum, S ^a   Liao, C ^a   Garg, A X ^c   Lentine, K L ^d   Segev, D L ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c WESTERN UNIVERSITY   (Canada)

^d SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

clinical research practice; donors and donation: living; kidney transplantation nephrology; kidney transplantation: living donor

Indexed keywords

ADULT; ARTICLE; CLINICAL OUTCOME; COHORT ANALYSIS; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT RECIPIENT; HIGH RISK PATIENT; HUMAN; KIDNEY ALLOGRAFT; KIDNEY DONOR; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; ALLOGRAFT; CHRONIC KIDNEY FAILURE; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; KIDNEY FUNCTION TEST; KIDNEY TRANSPLANTATION; MIDDLE AGED; NEPHRECTOMY; POSTOPERATIVE COMPLICATION; PROGNOSIS; SURVIVAL RATE; TRANSPLANTATION; YOUNG ADULT;

ADULT; ALLOGRAFTS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GRAFT SURVIVAL; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; NEPHRECTOMY; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; TISSUE AND ORGAN HARVESTING; YOUNG ADULT;

EID: 84977504883     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13869     Document Type: Article

References (35)

1. Mjoen G, Hallan S, Hartmann A, et al. Long-term risks for kidney donors. Kidney Int 2014; 86: 162–167.
2. Muzaale AD, Massie AB, Wang MC, et al. Risk of end-stage renal disease following live kidney donation. JAMA 2014; 311: 579–586.
3. Grams ME, Sang Y, Levey AS, et al. Kidney-failure risk projection for the living kidney-donor candidate. N Engl J Med 2016; 374: 411–421.
4. Bia MJ, Ramos EL, Danovitch GM, et al. Evaluation of living renal donors. The current practice of US transplant centers. Transplantation 1995; 60: 322–327.
5. Poggio ED, Braun WE, Davis C. The science of Stewardship: Due diligence for kidney donors and kidney function in living kidney donation–evaluation, determinants, and implications for outcomes. Clin J Am Soc Nephrol 2009; 4: 1677–1684.
6. Steiner RW, Ix JH, Rifkin DE, Gert B. Estimating risks of de novo kidney diseases after living kidney donation. Am J Transplant 2014; 14: 538–544.
7. Kido R, Shibagaki Y, Iwadoh K, et al. How do living kidney donors develop end-stage renal disease? Am J Transplant 2009; 9: 2514–2519.
8. Kasiske BL, Anderson-Haag T, Ibrahim HN, et al. A prospective controlled study of kidney donors: Baseline and 6-month follow-up. Am J Kidney Dis 2013; 62: 577–586.
9. Coresh J, Turin TC, Matsushita K, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA 2014; 311: 2518–2531.
10. Chauhan A, Diwan TS, Palacios CRF, et al. Using implantation biopsies as a surrogate to evaluate selection criteria for living kidney donors. Transplantation 2013; 96: 975–980.
11. Kasiske BL, Ravenscraft M, Ramos EL, Gaston RS, Bia MJ, Danovitch GM. The evaluation of living renal transplant donors: Clinical practice guidelines. Ad Hoc Clinical Practice Guidelines Subcommittee of the Patient Care and Education Committee of the American Society of Transplant Physicians. Journal of the American Society of Nephrology. JASN. 1996; 7: 2288–2313.
12. Mandelbrot DA, Pavlakis M, Danovitch GM, et al. The medical evaluation of living kidney donors: A survey of US transplant centers. Am J Transplant 2007; 7: 2333–2343.
13. Garg AX, Muirhead N, Knoll G, et al. Proteinuria and reduced kidney function in living kidney donors: A systematic review, meta-analysis, and meta-regression. Kidney Int 2006; 70: 1801–1810.
14. Goecke H, Ortiz AM, Troncoso P, et al. Influence of the kidney histology at the time of donation on long term kidney function in living kidney donors. Transpl Proc 2005; 37: 3351–3353.
15. Rule AD, Amer H, Cornell LD, et al. The association between age and nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med 2010; 152: 561–567.
16. Ohashi Y, Thomas G, Nurko S, et al. Association of metabolic syndrome with kidney function and histology in living kidney donors. Am J Transplant 2013; 13: 2342–2351.
17. Elsherbiny HE, Alexander MP, Kremers WK, et al. Nephron hypertrophy and glomerulosclerosis and their association with kidney function and risk factors among living kidney donors. Clin J Am Soc Nephrol 2014; 9: 1892–1902.
18. Yoon YE, Choi KH, Lee KS, Kim KH, Yang SC, Han WK. Impact of metabolic syndrome on postdonation renal function in living kidney donors. Transpl Proc 2015; 47: 290–294.
19. Cherikh WS, Young CJ, Kramer BF, Taranto SE, Randall HB, Fan PY. Ethnic and gender related differences in the risk of end-stage renal disease after living kidney donation. Am J Transplant 2011; 11: 1650–1655.
20. Levine GN, McCullough KP, Rodgers AM, Dickinson DM, Ashby VB, Schaubel DE. Analytical methods and database design: Implications for transplant researchers, 2005. Am J Transplant 2006; 6(5 Pt 2): 1228–1242.
21. Segev DL, Muzaale AD, Caffo BS, et al. Perioperative mortality and long-term survival following live kidney donation. JAMA 2010; 303: 959–966.
22. Montgomery RA, Lonze BE, King KE, et al. Desensitization in HLA-incompatible kidney recipients and survival. N Engl J Med 2011; 365: 318–326.
23. Muzaale AD, Dagher NN, Montgomery RA, Taranto SE, McBride MA, Segev DL. Estimates of early death, acute liver failure, and long-term mortality among live liver donors. Gastroenterology 2012; 142: 273–280.
24. Berger JC, Muzaale AD, James N, et al. Living kidney donors ages 70 and older: Recipient and donor outcomes. Clin J Am Soc Nephrol 2011; 6: 2887–2893.
25. Van Arendonk KJ, Orandi BJ, James NT, Segev DL, Colombani PM. Living unrelated renal transplantation: A good match for the pediatric candidate? J Pediatr Surg 2013; 48: 1277–1282.
26. Stuart EA. Matching methods for causal inference: A review and a look forward. Stat Sci 2010; 25: 1–21.
27. Scientific Registry of Transplant Recipients website. Risk-Adjustment Models. [cited 2015 Apr 17]. Available from: http://www.srtr.org/csr/current/modtabs.aspx.
28. Reeves-Daniel AM, DePalma JA, Bleyer AJ, et al. The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant 2011; 11: 1025–1030.
29. Suzuki K, Honda K, Tanabe K, Toma H, Nihei H, Yamaguchi Y. Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int 2003; 63: 2286–2294.
30. Choi SR, Sun IO, Hong YA, et al. The role of kidney biopsy to determine donation from prospective kidney donors with asymptomatic urinary abnormalities. Transpl Proc 2012; 44: 11–13.
31. Koushik R, Garvey C, Manivel JC, Matas AJ, Kasiske BL. Persistent, asymptomatic, microscopic hematuria in prospective kidney donors. Transplantation 2005; 80: 1425–1429.
32. Woestenburg AT, Verpooten GA, Ysebaert DK, Van Marck EA, Verbeelen D, Bosmans JL. Fibrous intimal thickening at implantation adversely affects long-term kidney allograft function. Transplantation 2009; 87: 72–78.
33. Sofue T, Inui M, Kiyomoto H, et al. Pre-existing arteriosclerotic intimal thickening in living-donor kidneys reflects allograft function. Am J Nephrol 2012; 36: 127–135.
34. Wu EH, Wojciechowski D, Chandran S, et al. Prevalence of abdominal aortic calcifications in older living renal donors and its effect on graft function and histology. Transpl Int 2015; 28: 1172–1178.
35. Zaky Z, Lankowsky B, Shah S, et al. Implications of living donor kidney histology, volume and function on Post-donation GFR [abstract]. Am J Transplant 2015 [cited 2015 Jul 25]; 15 (Suppl 3). Available from: http://www.atcmeetingabstracts.com/abstract/implications-of-living-donor-kidney-histology-volume-and-functiononpost-donation-gfr/.